Trojan J - Search Results

1

Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial.

Rimassa L, Porta C, Borbath I, Daniele B, Finn RS, Raoul JL, Schwartz LH, He AR, Trojan J, Peck-Radosavljevic M, Abbadessa G, Goldberg T, Santoro A, Bruix J. Rimassa L, et al. Among authors: trojan j. Hepat Oncol. 2014 Apr;1(2):181-188. doi: 10.2217/hep.14.3. Epub 2014 Jan 29. Hepat Oncol. 2014. PMID: 30190953 Free PMC article. Review.

2

Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge.

Welker MW, Bechstein WO, Zeuzem S, Trojan J. Welker MW, et al. Among authors: trojan j. Transpl Int. 2013 Feb;26(2):109-18. doi: 10.1111/j.1432-2277.2012.01562.x. Epub 2012 Sep 21. Transpl Int. 2013. PMID: 22994652 Free article. Review.

3

Nivolumab for the treatment of hepatocellular carcinoma.

Finkelmeier F, Waidmann O, Trojan J. Finkelmeier F, et al. Among authors: trojan j. Expert Rev Anticancer Ther. 2018 Dec;18(12):1169-1175. doi: 10.1080/14737140.2018.1535315. Epub 2018 Oct 22. Expert Rev Anticancer Ther. 2018. PMID: 30304963 Review.

4

Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.

Welker MW, Trojan J. Welker MW, et al. Among authors: trojan j. Cancer Manag Res. 2013 Oct 8;5:337-47. doi: 10.2147/CMAR.S35029. Cancer Manag Res. 2013. PMID: 24204170 Free PMC article. Review.

5

Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives.

Welker MW, Trojan J. Welker MW, et al. Among authors: trojan j. World J Gastroenterol. 2011 Jul 14;17(26):3075-81. doi: 10.3748/wjg.v17.i26.3075. World J Gastroenterol. 2011. PMID: 21912449 Free PMC article.

6

Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.

Vogl TJ, Nour-Eldin NE, Emad-Eldin S, Naguib NN, Trojan J, Ackermann H, Abdelaziz O. Vogl TJ, et al. Among authors: trojan j. World J Gastroenterol. 2011 Mar 14;17(10):1267-75. doi: 10.3748/wjg.v17.i10.1267. World J Gastroenterol. 2011. PMID: 21455325 Free PMC article.

7

Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.

Decaens T, Barone C, Assenat E, Wermke M, Fasolo A, Merle P, Blanc JF, Grando V, Iacobellis A, Villa E, Trojan J, Straub J, Bruns R, Berghoff K, Scheele J, Raymond E, Faivre S. Decaens T, et al. Among authors: trojan j. Br J Cancer. 2021 Jul;125(2):190-199. doi: 10.1038/s41416-021-01334-9. Epub 2021 Apr 6. Br J Cancer. 2021. PMID: 33824476 Free PMC article. Clinical Trial.

8

To bead or not to bead: is transarterial chemoembolization with Doxorubicin-eluting beads a new standard of care in hepatocellular carcinoma?

Trojan J, Zeuzem S. Trojan J, et al. Gastroenterology. 2010 Aug;139(2):690-2. doi: 10.1053/j.gastro.2010.06.035. Epub 2010 Jun 20. Gastroenterology. 2010. PMID: 20600058 No abstract available.

9

Established and Potential Predictive Biomarkers in Gastrointestinal Cancer--c-Kit, Her2, Ras and Beyond.

Koch C, Trojan J. Koch C, et al. Among authors: trojan j. Digestion. 2015;91(4):294-302. doi: 10.1159/000376573. Epub 2015 Apr 30. Digestion. 2015. PMID: 25924988 Review.

10

Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?

Trojan J, Sarrazin C. Trojan J, et al. Am J Gastroenterol. 2016 Aug;111(8):1208-9. doi: 10.1038/ajg.2016.214. Am J Gastroenterol. 2016. PMID: 27481429 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters